查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386201

成人疫苗市場報告：2030 年趨勢、預測與競爭分析

Adult Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

成人疫苗趨勢和預測

至2030年，全球成人疫苗市場預計將達到244億美元，2024年至2030年的複合年成長率為6.1%。該市場的主要促進因素是傳染病數量的增加以及政府為提高民眾對疫苗接種重要性的認知而採取的支持措施。全球成人疫苗市場的未來看起來充滿希望，為私人醫療保健公司和公立醫院市場帶來了機會。

成人疫苗市場洞察

Lucintel 預測，由於多效價疫苗在預防細菌和病毒性疾病方面的廣泛應用，預計在預測期內將出現高速成長。

在這個市場中，私人醫療保健公司預計將在預測期內實現高速成長。

由於政府對免疫計劃的大力支持以及該地區強大的醫療基礎設施的存在，預計北美在預測期內將出現最高的成長。

市場規模/估計：以金額估計成人疫苗的市場規模（十億美元）。

趨勢和預測分析：各個區隔市場和地區的市場趨勢（2018-2023）和預測（2024-2030）。

區隔分析：依技術、疫苗類型、最終用途和地區分類的成人疫苗市場規模（金額（十億美元））。

區域分析：北美、歐洲、亞太地區以及世界其他地區、中東和非洲成人疫苗市場區隔。

成長機會：依成人疫苗市場的技術、疫苗類型、最終用途和地區進行成長機會分析。

策略分析：成人疫苗市場併購、新產品開發、競爭形勢等。

基於波特五力模型的產業競爭實力分析。

本報告回答了 11 個關鍵問題：

  • Q.1. 區隔市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個區隔市場將以更快的速度成長？為什麼？
  • Q.3.哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要課題和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去五年發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章執行摘要

第2章全球成人疫苗市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與課題

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球成人疫苗市場趨勢（2018-2023）與預測（2024-2030）
  • 依技術分類的全球成人疫苗市場
    • 原始弱化
    • 失活
    • 次單元
    • 類毒素
    • 組合型
    • 其他
  • 依疫苗類型分類的全球成人疫苗市場
    • 單價
    • 多效價的
  • 全球成人疫苗市場（依最終用途）
    • 私人醫療公司
    • 公立醫院

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球成人疫苗市場區域分佈
  • 北美成人疫苗市場
  • 歐洲成人疫苗市場
  • 亞太地區成人疫苗市場
  • 其他地區成人疫苗市場

第5章競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球成人疫苗市場成長機會（依技術）
    • 依疫苗類型分類的全球成人疫苗市場成長機會
    • 全球成人疫苗市場成長機會（依最終用途）
    • 全球成人疫苗市場成長機會（依地區）
  • 全球成人疫苗市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球成人疫苗市場產能擴張
    • 全球成人疫苗市場的合併、收購與合資企業
    • 認證和許可

第7章主要企業概況

  • Glaxosmithkline
  • Merck & CO
  • Sanofi
  • Johnson & Johnson
  • Serum institute India
  • AstraZeneca
  • Novartis
簡介目錄

Adult Vaccine Trends and Forecast

The future of the global adult vaccine market looks promising with opportunities in the private healthcare firm and government hospital markets. The global adult vaccine market is expected to reach an estimated $24.4 billion by 2030 with a CAGR of 6.1% from 2024 to 2030. The major drivers for this market are growing cases of contagious diseases and supportive government initiatives to spread awareness about the importance of vaccination among population.

A more than 150-page report is developed to help in your business decisions.

Adult Vaccine by Segment

The study includes a forecast for the global adult vaccine by technology, vaccine type, end use, and region.

Adult Vaccine Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Live Attenuated
  • Inactivated
  • Subunit
  • Toxoid
  • Conjugate
  • Others

Adult Vaccine Market by Vaccine Type [Shipment Analysis by Value from 2018 to 2030]:

  • Monovalent
  • Multivalent

Adult Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Private Healthcare Firms
  • Government Hospitals

Adult Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Adult Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies adult vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the adult vaccine companies profiled in this report include-

  • Glaxosmithkline
  • Merck & Co
  • Sanofi
  • Johnson & Johnson
  • Serum Institute India
  • Astrazeneca
  • Novartis

Adult Vaccine Market Insights

Lucintel forecasts that multivalent is expected to witness higher growth over the forecast period due to its broader application to protect against bacterial and viral illnesses.

Within this market, private healthcare firm is expected to witness higher growth over the forecast period.

North America is expected to witness highest growth over the forecast period due to presence of strong government support for immunization programs and existence of robust healthcare infrastructure in the region.

Features of the Global Adult Vaccine Market

Market Size Estimates: Adult vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Adult vaccine market size by technology, vaccine type, end use, and region in terms of value ($B).

Regional Analysis: Adult vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technologies, vaccine types, end uses, and regions for the adult vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the adult vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the adult vaccine market size?

Answer: The global adult vaccine market is expected to reach an estimated $24.4 billion by 2030.

Q.2 What is the growth forecast for adult vaccine market?

Answer: The global adult vaccine market is expected to grow with a CAGR of 6.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the adult vaccine market?

Answer: The major drivers for this market are growing cases of contagious diseases and supportive government initiatives to spread awareness about the importance of vaccination among population.

Q4. What are the major segments for adult vaccine market?

Answer: The future of the adult vaccine market looks promising with opportunities in the private healthcare firm and government hospital markets.

Q5. Who are the key adult vaccine market companies?

Answer: Some of the key adult vaccine companies are as follows:

  • Glaxosmithkline
  • Merck & Co
  • Sanofi
  • Johnson & Johnson
  • Serum Institute India
  • Astrazeneca
  • Novartis

Q6. Which adult vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that multivalent is expected to witness higher growth over the forecast period due to its broader application to protect against bacterial and viral illnesses.

Q7. In adult vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to presence of strong government support for immunization programs and existence of robust healthcare infrastructure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the adult vaccine market by technology (live attenuated, inactivated, subunit, toxoid, conjugate , and others), vaccine type (monovalent and multivalent), end use (private healthcare firms and government hospitals), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Adult Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Adult Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Adult Vaccine Market by Technology
    • 3.3.1: Live Attenuated
    • 3.3.2: Inactivated
    • 3.3.3: Subunit
    • 3.3.4: Toxoid
    • 3.3.5: Conjugate
    • 3.3.6: Others
  • 3.4: Global Adult Vaccine Market by Vaccine Type
    • 3.4.1: Monovalent
    • 3.4.2: Multivalent
  • 3.5: Global Adult Vaccine Market by End Use
    • 3.5.1: Private Healthcare Firms
    • 3.5.2: Government Hospitals

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Adult Vaccine Market by Region
  • 4.2: North American Adult Vaccine Market
    • 4.2.1: North American Adult Vaccine Market by Vaccine Type: Monovalent and Multivalent
    • 4.2.2: North American Adult Vaccine Market by End Use: Private Healthcare Firms and Government Hospitals
  • 4.3: European Adult Vaccine Market
    • 4.3.1: European Adult Vaccine Market by Vaccine Type: Monovalent and Multivalent
    • 4.3.2: European Adult Vaccine Market by End Use: Private Healthcare Firms and Government Hospitals
  • 4.4: APAC Adult Vaccine Market
    • 4.4.1: APAC Adult Vaccine Market by Vaccine Type: Monovalent and Multivalent
    • 4.4.2: APAC Adult Vaccine Market by End Use: Private Healthcare Firms and Government Hospitals
  • 4.5: ROW Adult Vaccine Market
    • 4.5.1: ROW Adult Vaccine Market by Vaccine Type: Monovalent and Multivalent
    • 4.5.2: ROW Adult Vaccine Market by End Use: Private Healthcare Firms and Government Hospitals

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Adult Vaccine Market by Technology
    • 6.1.2: Growth Opportunities for the Global Adult Vaccine Market by Vaccine Type
    • 6.1.3: Growth Opportunities for the Global Adult Vaccine Market by End Use
    • 6.1.4: Growth Opportunities for the Global Adult Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Adult Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Adult Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Adult Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Glaxosmithkline
  • 7.2: Merck & CO
  • 7.3: Sanofi
  • 7.4: Johnson & Johnson
  • 7.5: Serum institute India
  • 7.6: AstraZeneca
  • 7.7: Novartis